phase 1 trial
Showing 1 - 25 of >10,000
Breast Cancer Trial (CBD Oral, Control)
Not yet recruiting
- Breast Cancer
- CBD Oral
- Control
- (no location specified)
Nov 18, 2023
Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended
Not yet recruiting
- Cancer
- +3 more
- 177Lu-PSMA-I&T - escalating renal absorbed dose
- 177Lu-PSMA-I&T - recommended phase 2 regime
- (no location specified)
Jun 14, 2023
Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)
Not yet recruiting
- Alpha-1 Antitrypsin Deficiency
- VX-668
- Placebo
- (no location specified)
Feb 3, 2023
Solid Tumor Trial in Birtinya (IBI130)
Not yet recruiting
- Solid Tumor
-
Birtinya, Queensland, AustraliaSunshine Coast University
Jun 19, 2023
Advanced Solid Tumors Trial (AMG 305)
Not yet recruiting
- Advanced Solid Tumors
- AMG 305
- (no location specified)
Mar 24, 2023
Exocrine Pancreatic Insufficiency Trial in Ann Arbor (ANG003)
Recruiting
- Exocrine Pancreatic Insufficiency
-
Ann Arbor, MichiganUniversity of Michigan Medical Center
Sep 18, 2023
Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)
Recruiting
- Adrenocortical Carcinoma
- 68Ga-R8760 injection at pre-defined dose levels
- 68GA-R8760 injection
-
Ann Arbor, MichiganUniversity of Michigan Nuclear Medicine
Aug 11, 2023
Healthy Volunteers Trial in Melbourne (Verasone)
Not yet recruiting
- Healthy Volunteers
-
Melbourne, Victoria, AustraliaNucleus Network
Nov 19, 2023
Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))
Recruiting
- Duchenne Muscular Dystrophy
- Phase 1, SQY51
- +3 more
-
Garches, FranceHôpital Raymond Poincaré
Mar 7, 2023
Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)
Not yet recruiting
- Ischemia-reperfusion Injury
- BX-001N Part 1
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Oct 19, 2023
Corneal Edema, Corneal Endothelial Dysfunction Trial (AURN001)
Not yet recruiting
- Corneal Edema
- Corneal Endothelial Dysfunction
- AURN001
- (no location specified)
Sep 11, 2023
Advanced Solid Tumor Trial in Boston (VAX014)
Not yet recruiting
- Advanced Solid Tumor
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 2, 2023
Advanced Cancer Trial in South Brisbane, Bedford Park, Melbourne (AWT020)
Recruiting
- Advanced Cancer
- AWT020
-
South Brisbane, Queensland, Australia
- +2 more
Oct 18, 2023
Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- NS-050/NCNP-03
- Placebo
- (no location specified)
Sep 19, 2023
Healthy Trial in Madison (Fadraciclib)
Active, not recruiting
- Healthy
-
Madison, WisconsinLabcorp Clinical Research Unit
Apr 5, 2023
Healthy Trial in Christchurch (LTG-001, Placebo)
Not yet recruiting
- Healthy
- LTG-001
- Placebo
-
Christchurch, New ZealandClinical Research Unit
Sep 21, 2023
Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)
Not yet recruiting
- Prostate Cancer
- Lutetium Lu 177 JH020002 Injection
- (no location specified)
Nov 14, 2023
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)
Not yet recruiting
- Solid Tumor, Adult
- +2 more
- (no location specified)
May 3, 2023